Floatz logo

MVT-5873 (FULLY HUMAN, IGG1 ANTIBODY TARGETING SIALYL LEWIS A)

Liver Metastasis

National Cancer Institute (NCI)monoclonal_antibodyPhase 2Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
26/ 100
Competitive Position
81/ 100

Competitive context

16 Active assets in the Liver Metastasis cohort.

Asset / SponsorPhaseRating
Eloxatin
Tianjin Medical University Cancer Institute and Hospital
Phase 3BB
FLUOROURACILUM
National Taiwan University Hospital
Phase 3BB
Calcium folinate pentahydrate
National Taiwan University Hospital
Phase 3BB
Talaporfin
Light Sciences LLC
Phase 2BB
Irinotecan
Tianjin Medical University Cancer Institute and Hospital
Phase 3B

View all 30 →

Same molecule, other indications

MVT-5873 (FULLY HUMAN, IGG1 ANTIBODY TARGETING SIALYL LEWIS A) is also rated in:

pancreatic neoplasmDormant
CC
Indicative ·
41 / 100
View asset →
colon carcinomaDormant
CC
Indicative ·
41 / 100
View asset →
cholangiocarcinomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →